GEN Exclusives

More »

GEN News Highlights

More »
Mar 3, 2008

Raven and Emory University Scientist Team Up for Prostate Cancer Stem Cell Research

  • Raven biotechnologies and a researcher at Emory University Medical School entered a cancer stem cell research collaboration. With the focus on prostate cancer, the partners will also assess the development of diagnostic and prognostic tests.

    Leland W.K. Chung, Ph.D., director of the molecular urology and therapeutics program at the Emory University Medical School’s department of urology will have access to Raven’s prostate cancer stem cells. Dr. Chung and the company will examine prostate cancer biology, disease progression, and subsequent metastasis.

    Raven will also provide Emory with a library of antibodies targeting cancer stem cells to study their use as prognostic devices and to monitor treatment.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?